Filing Details
- Accession Number:
- 0001179110-13-013100
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2013-08-13 18:10:02
- Reporting Period:
- 2013-08-02
- Filing Date:
- 2013-08-13
- Accepted Time:
- 2013-08-13 18:10:02
- Original Submission Date:
- 2013-08-06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
884629 | Actavis Inc. | ACT | Pharmaceutical Preparations (2834) | 953872914 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1499481 | O Sigurdur Olafsson | Morris Corporate Center Iii 400 Interpace Parkway Parsippany NJ 07054 | Pres-Global Generics | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.0033 | Disposition | 2013-08-02 | 4,500 | $135.47 | 84,643 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Actavis, Inc., as amended.
- This amendment to Form 4 is filed solely to correct the transaction code in Box 3 to reflect a sale rather than a forteiture of shares on the transaction date.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.27 to $135.69, inclusive. The reporting person undertakes to provide to Actavis, Inc., any security holder to Actavis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.